Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | -3.65% | -10.81% | -24.13% |
Business Summary
Number of employees: 11
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products and Medical Therapies
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +21.70% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +21.70% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 18-09-30 |
Robert Kristal
DFI | Director of Finance/CFO | - | 21-11-03 |
Compliance Officer | 55 | 15-08-31 | |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 11-04-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 21-10-28 |
David Rosa
BRD | Director/Board Member | 59 | 21-10-28 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 11-04-12 |
Nickolay Kukekov
BRD | Director/Board Member | 49 | 21-03-17 |
Lance Alstodt
CEO | Chief Executive Officer | 53 | 18-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,398,158 | 0 | 0 | 81.20 % |
Stock B | 1 | 6,769,919 | 5,497,141 ( 81.20 %) | 0 |
Company contact information
BioRestorative Therapies, Inc.
40 Marcus Drive Suite 1
11747, Melville
+631 760 8100
http://www.biorestorative.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.13% | 9.27M | |
+5.06% | 109B | |
+11.15% | 105B | |
-0.38% | 22.25B | |
-12.12% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.03% | 16.85B | |
+3.32% | 13.76B | |
+35.95% | 12.46B |
- Stock Market
- Equities
- BRTX Stock
- Company BioRestorative Therapies, Inc.